German Exhibitors
Axiom Insights, a University of Hamburg & DESY spin-off, provides advanced X-Ray Fluorescence Imaging (XFI): non-invasive whole-body tracking of drugs and cells for preclinical R&D
Bayern International has made promoting the exports of small and medium sized Bavarian companies its goal.
biotechrabbit covers the whole workflow from enzyme production and formulation development to large-scale production and lyophilization for molecular diagnostics and life sciences.
BioM Biotech Cluster Development GmbH
As a non-profit organization, Bio M creates a unique ecosystem in medicine and biotechnology for innovation, growth, and value creation in Bavaria.
CheckImmune offers lab services, data interpretation & consulting for biomarkers—specializing in immunology. Innovative and science-driven.
At FyoniBio, we offer biopharmaceutical services across different stages of drug development. All services are performed according to ISO 9001:2012 or GCLP.
HEALTH MADE IN GERMANY/GERMANY TRADE & INVEST
Germany Trade & Invest (GTAI) is Germany's international economic promotion agency HEALTH MADE IN GERMANY is the Export Initiative for the German Healthcare Industry.
Access 100+ years of biologics manufacturing expertise. IDT Biologika is a German CDMO committed to quality, regulatory compliance, and long-term partnership.
Iris Biotech provides high quality products for peptide-synthesis, linkerology and drug-delivery. We have the know-how to manufacture your desired compound as custom synthesis.
MyBiotech is a German CDMO for nanoparticle and parenteral drug products, offering development, GMP manufacturing, fill & finish, lyophilisation, QC and stability.
Your partner of choice in bringing therapeutics to life. In your quest to advance health care, the right partner can make all the difference.
We are a life science company producing human platelet lysate, a xeno-free cell culture supplement for various applications, from basic laboratory research to GMP cell therapies.
Proteros partners with pharma and biotech companies across the US, Europe, and Japan to unlock the toughest early drug discovery targets.